Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Hypoglycemia following inadvertent and factitious sulfonylurea overdosages.

Klonoff DC, Barrett BJ, Nolte MS, Cohen RM, Wyderski R.

Diabetes Care. 1995 Apr;18(4):563-7. Review.

PMID:
7497872
2.

Are one or two dangerous? Sulfonylurea exposure in toddlers.

Little GL, Boniface KS.

J Emerg Med. 2005 Apr;28(3):305-10. Review.

PMID:
15769574
3.

Octreotide for the treatment of sulfonylurea poisoning.

Glatstein M, Scolnik D, Bentur Y.

Clin Toxicol (Phila). 2012 Nov;50(9):795-804. doi: 10.3109/15563650.2012.734626. Epub 2012 Oct 10. Review.

PMID:
23046209
4.

Inadvertent sulfonylurea-induced hypoglycemia. A dangerous, but preventable condition.

Huminer D, Dux S, Rosenfeld JB, Pitlik SD.

Arch Intern Med. 1989 Aug;149(8):1890-2. Review.

PMID:
2504124
5.

Octreotide's role in the management of sulfonylurea-induced hypoglycemia.

Dougherty PP, Klein-Schwartz W.

J Med Toxicol. 2010 Jun;6(2):199-206. doi: 10.1007/s13181-010-0064-z. Review.

6.

The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration.

Lebowitz MR, Blumenthal SA.

Arch Intern Med. 1993 Mar 8;153(5):650-5. Review. Erratum in: Arch Intern Med 1993 Jun 14;153(11):1310.

PMID:
8439228
7.

Use of sulfonylurea agents in older diabetic patients.

Peters AL, Davidson MB.

Clin Geriatr Med. 1990 Nov;6(4):903-21. Review.

PMID:
2224754
8.

Insulin & C-peptide levels in sulfonylurea-induced hypoglycemia: a systematic review.

DeWitt CR, Heard K, Waksman JC.

J Med Toxicol. 2007 Sep;3(3):107-18. Review.

9.

Factitious and artifactual hypoglycemia.

Horwitz DL.

Endocrinol Metab Clin North Am. 1989 Mar;18(1):203-10. Review.

PMID:
2645127
10.

[Hypoglycemia in diabetes mellitus].

Irsigler K.

Acta Med Austriaca. 1992;19(4):100-5. Review. German.

PMID:
1290316
11.

Octreotide for sulfonylurea-induced hypoglycemia following overdose.

Carr R, Zed PJ.

Ann Pharmacother. 2002 Nov;36(11):1727-32. Review.

PMID:
12398568
12.
13.

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.

Chilcott J, Tappenden P, Jones ML, Wight JP.

Clin Ther. 2001 Nov;23(11):1792-823; discussion 1791. Review.

PMID:
11768834
14.

Hypoglycemic adverse reactions to insulin and sulfonylureas.

O'Donnell J.

Leg Med. 1993:193-232. Review.

PMID:
8121229
15.

Sulphonylureas and metformin overdose: clinical features and management.

Bates N.

Emerg Nurse. 2001 May;9(2):18-22. Review. No abstract available.

PMID:
11935618
16.

Features, prevention and management of acute overdose due to antidiabetic drugs.

Moore DF, Wood DF, Volans GN.

Drug Saf. 1993 Sep;9(3):218-29. Review. Erratum in: Drug Saf 1994 Sep;11(3):212.

PMID:
8240727
17.

Hypoglycemia: factitious and felonious.

Marks V, Teale JD.

Endocrinol Metab Clin North Am. 1999 Sep;28(3):579-601. Review.

PMID:
10500932

Supplemental Content

Support Center